ProShare Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-43,870
Closed -$28K 2190
2022
Q1
$28K Sell
43,870
-7,248
-14% -$5.58K ﹤0.01% 2160
2021
Q4
$57K Buy
51,118
+21,134
+70% +$32.7K ﹤0.01% 2272
2021
Q3
$55K Sell
29,984
-30,719
-51% -$69K ﹤0.01% 1958
2021
Q2
$192K Buy
+60,703
New +$152K ﹤0.01% 2157
2019
Q4
Sell
-1,613
Closed -$13K 1808
2019
Q3
$13K Buy
1,613
+266
+20% +$3.62K ﹤0.01% 1650
2019
Q2
$24K Sell
1,347
-35
-3% -$766 ﹤0.01% 1609
2019
Q1
$43K Buy
1,382
+87
+7% +$2.92K ﹤0.01% 1620
2018
Q4
$38K Sell
1,295
-209
-14% -$9.5K ﹤0.01% 1535
2018
Q3
$113K Sell
1,504
-76
-5% -$5.14K ﹤0.01% 1670
2018
Q2
$90K Buy
+1,580
New +$57.5K ﹤0.01% 1717
2017
Q1
Sell
-860
Closed -$15K 1670
2016
Q4
$15K Buy
+860
New +$17.6K ﹤0.01% 1737
2014
Q4
Sell
-867
Closed -$49K 2146
2014
Q3
$49K Sell
867
-196
-18% -$10.6K ﹤0.01% 2264
2014
Q2
$70K Buy
+1,063
New +$61.4K ﹤0.01% 2422

Other funds holding ASXC

ProShare Advisors's ASXC Position: Q2 2022 in Review

ProShare Advisors sold out of Asensus Surgical, Inc. (ASXC) in Q2 2022, closing a stake of 43,870 shares — an estimated $28K sold.

ProShare Advisors first reported a position in ASXC in Q2 2014 and held it in 13 quarters. The position peaked at $192K in Q2 2021. 91 funds tracked by Wall St. Rank hold ASXC as of Q2 2022.

  • ProShare Advisors reported no remaining Asensus Surgical, Inc. position as of Q2 2022 after selling out during the quarter.
  • ProShare Advisors sold 43,870 Asensus Surgical, Inc. shares in Q2 2022, an estimated $28K.
  • ProShare Advisors first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 13 quarters.
  • ProShare Advisors's Asensus Surgical, Inc. position peaked at $192K in Q2 2021.
  • 91 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2022.

Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.